Sponsor Pipeline

Shanghai Hengrui Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
27
Active Trials
23
Recruiting
2
Phase 3
8
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06439589
Phase Ib/II Study of HRS2398 in Combination With Adebrelimab in Patients With Advanced…
overall status: Recruiting → Unknown
Active Trials by Phase
Phase 3
2
Phase 2
6
Phase 1/2
11
Phase 1
8
Active Trials — top 25 of 27
NCT IDTitleConditionStatus
Phase 3
NCT06738251 A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced… Advanced Urothelial Carcinoma Recruiting
NCT06649292 SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens… Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Recruiting
Phase 2
NCT06654440 A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy Advanced Gynecological Malignancy Recruiting
NCT06895928 A Trial of SHR-A2102 With Other Antitumor Therapies in Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07229729 A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable… Non-small Cell Lung Cancer Recruiting
NCT07268040 A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With… Malignant Solid Tumors Recruiting
NCT06704828 A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor… Advanced Solid Tumors Not Yet Recruiting
NCT05593250 A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma Asthma Active, Not Recruiting
Phase 1/2
NCT06605222 A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT06589778 A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With… Non-Small Cell Lung Cancer Recruiting
NCT06639347 A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma Advanced Urothelial Carcinoma Recruiting
NCT06417554 A Trial of SHR-A2102 With or Without Antitumor Therapy in Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT06474468 A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced… Advanced or Metastatic Esophageal Cancer Recruiting
NCT05410730 A Study of SHR-1501 Alone or in Combination With BCG or SHR-1316 in Subjects With NMIBC High-risk NMIBC Recruiting
NCT07229586 A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors Solid Tumor Recruiting
NCT06512051 A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced… Advanced or Metastatic Non-small Cell Lung Cancer Recruiting
NCT07296341 HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors Locally Advanced or Metastatic Pancreatic Cancer With Recruiting
NCT07073534 Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With… Patients With Advanced or Metastatic Malignant Tumors Recruiting
NCT06474455 A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor… Advanced Solid Tumors Recruiting
Phase 1
NCT06108492 A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of… Intermediate and High-risk Non-muscle Invasive Bladder Cancer Recruiting
NCT05701709 Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT05836948 The Clinical Study of SHR-9839 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT06350006 SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor CLDN18.2-positive Advanced Solid Tumor Recruiting
NCT07301333 A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects Pain Recruiting
NCT07490613 A Phase I Study of SHR-3836 in Patients With Multiple Myeloma Multiple Myeloma Recruiting
See all 27 active Shanghai Hengrui Pharmaceutical Co., Ltd. trials with filters →
Disease Areas
Get alerts when Shanghai Hengrui Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free